Advanced in Metastatic Brain Tumor

Joachim P. Steinbach

Frankfurt Am Main, HE, DE 
Advanced in Metastatic Brain Tumor
Frankfurt Am Main, HE, DE 
OverviewLocationsClinical Research

Overview

Joachim Steinbach practices in Frankfurt Am Main, Germany. Mr. Steinbach is rated as an Advanced expert by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Astrocytoma, Glioblastoma, Glioma, and Gliomatosis Cerebri.

His clinical research consists of co-authoring 192 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Metastatic Brain Tumor.

Gender
Male

Locations

Frankfurt Am Main, HE, Germany
Other Locations
Hannover, NI, Germany
Heidelberg, BW, Germany
Marburg An Der Lahn, HE, Germany
Nasen Und Ohrenkrankheiten, Plastische Und Ästhetische Operationen, Prof. Dr. Med. Dr. H.c. R. Hagen, Wuerzburg, BY, Germany
Magdeburg, ST, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase III Trial of Marizomib in Combination With Standard Temozolomide-based Radiochemotherapy Versus Standard Temozolomide-based Radiochemotherapy Alone in Patients With Newly Diagnosed Glioblastoma
A Phase III Trial of Marizomib in Combination With Standard Temozolomide-based Radiochemotherapy Versus Standard Temozolomide-based Radiochemotherapy Alone in Patients With Newly Diagnosed Glioblastoma
Enrollment Status: Completed
Publish Date: July 01, 2025
Intervention Type: Drug, Radiation
Study Drugs: Marizomib, Temozolomide
Study Phase: Phase 3
Calorie-restricted, Ketogenic Diet and Transient Fasting vs. Standard Nutrition During Reirradiation for Patients With Recurrent Glioblastoma: the ERGO2 Study
Calorie-restricted, Ketogenic Diet and Transient Fasting vs. Standard Nutrition During Reirradiation for Patients With Recurrent Glioblastoma: the ERGO2 Study
Enrollment Status: Completed
Publish Date: June 02, 2021
Intervention Type: Dietary supplement
Study Phase: Not Applicable
View 1 Less Clinical Trial

192 Total Publications

State of the art: glioma-associated epilepsy-bridging tumor biology and epileptogenesis.
State of the art: glioma-associated epilepsy-bridging tumor biology and epileptogenesis.
Journal: Neurological research and practice
Published: September 06, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Steinbach's expertise for a condition
ConditionClose
View All 18 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile